Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis B
2023
2020
Americas
Clear all
Type of publications
NITAG documentation
(70)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(73)
Africa
(12)
Eastern Mediterranean
(2)
Europe
(32)
South-East Asia
(3)
Western Pacific
(24)
Countries
Argentina
(1)
Canada
(9)
Chile
(10)
United States of America
(52)
Diseases
COVID-19
(72)
Hepatitis B
(1)
Dengue
(1)
Diphtheria
(1)
Hepatitis A
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Influenza
(6)
Meningococcal disease
(3)
Pertussis
(1)
Pneumococcal disease
(5)
Poliomyelitis
(1)
RSV (Respiratory syncytial virus)
(5)
Tetanus
(1)
Vaccine topics
Acceptance
(2)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(1)
All age groups
(2)
Children
(1)
Healthcare workers
(2)
Older adults
(1)
Risk group
(3)
Publication date
2023
(11)
2020
(62)
2024
(1)
2022
(42)
2021
(64)
2019
(1)
2018
(2)
2017
(1)
2011
(1)
2008
(1)
2006
(1)
2005
(1)
2000
(1)
73 results found
2020
∙
Megan Wallace, ACIP
Disparities in COVID-19 Incidence, Severity, and Outcomes
2020
∙
Tom Shimabukuro, ACIP
Enhanced safety monitoring for COVID-19 vaccines in early phase vaccination
2020
∙
ACIP
Epidemiology of COVID-19 in Essential Workers, including Healthcare Personnel
2020
∙
ACIP, Nancy McClung
Epidemiology of Individuals at Increased Risk of COVID-19 Disease
2020
∙
Mary Chamberland, ACIP
Ethical Principles for Phased Allocation of COVID-19 Vaccines
2020
∙
Sara Oliver, ACIP
EtR Framework: Moderna COVID-19 vaccine
2020
∙
ACIP, Sara Oliver
EtR Framework: Public Health Problem, Resource Use and Equity Domains
2020
∙
Sara Oliver, ACIP
EtR Framework: Values, Acceptability and Feasibility Domains
2020
∙
Sara Oliver, ACIP
Evidence to Recommendations Framework: Pfizer-BioNTech COVID-19 vaccine
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register